ӢQ:1,3,5-Tris(p-formylphenyl)benzeneӢͬx~:1,3,5-Tris(p-formylphenyl)benzene;1,4-Di-(p-benzaldehydyl)-naphthalene;HT014,5'-(4-Formylphenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbaldehyde
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0103634 | 100mg |
1
|
ԃr |
Q-0103634 | 250mg |
1
|
ԃr |
Q-0103634 | 500mg |
1
|
ԃr |
Q-0103634 | 1g |
1
|
ԃr |
Q-0103634 | 5g |
1
|
ԃr |
1,3,5-()Q
1,3,5-()
Ӣ 4-[3,5-bis(4-formylphenyl)phenyl]benzaldehyde
Ąe 4-[3,5-(4-)]ȩ
1,3,5-()W|
ʽ C27H18O3
390.43000
| 390.12600
PSA 51.21000
LogP 6.12510
PaƷ
(4--9-)
c
(+)-Biotin-PEG2-amine
(R,R)-DACH- Trost w
LDK378 Dihydrochloride
Velpatasvir intermediate
Sfgw
ƫX
һ
;
aأ
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
aSң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹ
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:(S)-(+)-Glycidyl-4-nitrobenzenesulfonateӢͬx~:(2S)-(+)-GLYCIDYL4-NITROBENZOATE;(S)-(+)-GLYCIDYL-4-NITROBENZOATE;(S)-(+)-GLYCIDYL-4-NITROBENZENESULFONATE
-
ӢQ:Dexamethasone-17-acetateӢͬx~:20-dione,9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-pregna-4-diene-3;